The global biological safety testing market, which was valued at USD 4.32 billion in 2022, is projected to reach USD 12.98 billion by 2032, with a compound annual growth rate (CAGR) of 13% throughout the forecast period. The growth of biologics and biosimilars in the pharmaceutical and biotechnology industries is a significant factor contributing to the increasing market revenue. The demand for...

The global Digital therapeutics market size was USD 4.8 billion in 2022 and is expected to reach USD 26.69 billion in 2032, and register a revenue CAGR of 21% during the forecast period A detailed analysis of the Global Digital Therapeutics Market 2023 is provided, including global, regional, and country-level market sizes, segmentation market growth, market share,...

The global hemostasis analyzers market was valued at USD 4.36 Billion in 2022 and is projected to reach USD 9.47 Billion by 2032, exhibiting a significant compound annual growth rate (CAGR) of 9% throughout the forecast period. Key drivers of market revenue growth include the increasing prevalence of bleeding disorders and the growing number of surgeries and trauma cases, as well as the...

The psoriasis treatment market is witnessing substantial growth globally, propelled by the increasing prevalence of psoriasis and a paradigm shift in treatment approaches. Psoriasis, a chronic autoimmune skin disorder, has led to a surge in demand for effective and targeted treatment options. Biologic therapies, in particular, have gained prominence, offering a novel and promising avenue for...

The smart hospital wearables market is witnessing substantial growth, driven by the integration of advanced technology into healthcare solutions. Recent market reports highlight a notable expansion in the global smart hospital wearables market, emphasizing the increasing adoption of wearable devices for patient monitoring, health tracking, and improving overall healthcare outcomes. The market...